secwatch.observer — SEC 8-K summary
======================================

Issuer:     PERRIGO Co plc (PRGO)
CIK:        0001585364
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001585364-26-000040
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perrigo completes sale of Dermacosmetics business for €305.6M upfront, plus contingent €27M
--------------------------------------------------------------------------------

- Upfront cash €305.6M (incl. €5.6M working capital); up to €27M contingent on net sales milestones over three years.
- Brands sold: ACO, Biodermal, Emolium, Iwostin; business generated ~€120M net sales (~5% of adj. op income) in 2025.
- Net proceeds will be used primarily for debt reduction, enhancing financial flexibility and strengthening balance sheet.
- Divestiture is part of Perrigo's Three-S plan to Stabilize, Streamline, and Strengthen the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585364/000158536426000040/0001585364-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585364/000158536426000040/prgo-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001585364-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer